Healthcare provider profile · identity verified

David J Mansour, MD

Internal Medicine · CLEVELAND, OH · NPI 1104923762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	648	184
Omeprazole	Omeprazole	317	82
Lisinopril	Lisinopril	290	90
Amlodipine Besylate	Amlodipine Besylate	277	80
Levothyroxine Sodium	Levothyroxine Sodium	188	57
Losartan Potassium	Losartan Potassium	178	55
Hydrochlorothiazide	Hydrochlorothiazide	170	58
Metoprolol Succinate	Metoprolol Succinate	168	52
Metformin Hcl	Metformin Hcl	144	43
Tamsulosin Hcl	Tamsulosin Hcl	138	39
Simvastatin	Simvastatin	109	31
Rosuvastatin Calcium	Rosuvastatin Calcium	105	35
Fluoxetine Hcl	Fluoxetine Hcl	104	26
Gabapentin	Gabapentin	97	38
Jardiance	Empagliflozin	86	23
Fluticasone Propionate	Fluticasone Propionate	81	29
Trazodone Hcl	Trazodone Hcl	79	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	suppressed
Xarelto	Rivaroxaban	71	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	22
Oxycodone Hcl	Oxycodone Hcl	68	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	67	27
Sertraline Hcl	Sertraline Hcl	67	21
Atenolol	Atenolol	65	20
Metoprolol Tartrate	Metoprolol Tartrate	65	23
Diclofenac Sodium	Diclofenac Sodium	64	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	22
Metformin Hcl Er	Metformin Hcl	62	18
Ozempic	Semaglutide	60	17
Furosemide	Furosemide	55	20
Allopurinol	Allopurinol	54	16
Pravastatin Sodium	Pravastatin Sodium	51	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	50	18
Eliquis	Apixaban	49	12
Glipizide Er	Glipizide	48	15
Doxazosin Mesylate	Doxazosin Mesylate	46	13
Duloxetine Hcl	Duloxetine Hcl	46	12
Lovastatin	Lovastatin	46	13
Bupropion Hcl Sr	Bupropion Hcl	42	12
Ibuprofen	Ibuprofen	42	19
Januvia	Sitagliptin Phosphate	41	suppressed
Verapamil Er	Verapamil Hcl	41	12
Naproxen	Naproxen	36	15
Topiramate	Topiramate	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Famotidine	Famotidine	35	13
Prednisone	Prednisone	35	21
Alprazolam	Alprazolam	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Finasteride	Finasteride	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	12
Clopidogrel	Clopidogrel Bisulfate	30	11
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Glipizide	Glipizide	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	11
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Spironolactone	Spironolactone	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Azithromycin	Azithromycin	19	13
Lorazepam	Lorazepam	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	17
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cephalexin	Cephalexin	18	14
Colchicine	Colchicine	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Repaglinide	Repaglinide	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Naloxone Hcl	Naloxone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibu	Ibuprofen	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Torsemide	Torsemide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error